TP53 and cancer: However, continuous treatment to reestablish the p53 functions could result in pharmacological resistance, since the increase in antioxidant activity in cancer cells would prevent cell death caused by exogenous stress generated by radiotherapy or the oxidant stress of a chemotherapeutical treatment (Conklin, 2004; Trachootham et al., 2009).